Jo Varshney

Jo Varshney is a prominent entrepreneur and biotechnology expert, serving as the Founder & CEO of VeriSIM Life since October 2017, where the company has created an AI-driven bio-simulation platform to enhance drug development outcomes in the pharmaceutical industry. In addition, Varshney holds the position of Chief Executive Officer at PulmoSIM Therapeutics, a biotech subsidiary of VeriSIM Life, and serves as an advisor for the Critical Path Institute and Global Predictions Inc. Notably, Varshney is an official member of the Forbes Technology Council and a network leader at Village Global. Previous experience includes roles as a scientific advisor at SVAI, a postdoctoral fellow at UCSF Medical Center, and a visiting research scientist at Genentech. Varshney's academic background includes a PhD in Comparative Oncology/Genomics from the University of Minnesota and a Master's Degree in Translational Pathobiology & Bioinformatics from Penn State University.